1. What This Condition Is
Hodgkin's disease (also called Hodgkin lymphoma) is a cancer of the lymphatic system characterized by the presence of Reed-Sternberg cells — abnormal giant cells derived from B-lymphocytes. It typically presents with painless enlargement of lymph nodes, most commonly in the neck, armpit, or groin, along with systemic symptoms including fever, night sweats, and unexplained weight loss (collectively called "B symptoms"). Hodgkin's disease is generally considered one of the most treatable lymphomas, with high cure rates in early-stage disease, but treatment — particularly the combination of chemotherapy and radiation — carries significant long-term health consequences.
Hodgkin's disease is one of the original 14 conditions listed as an Agent Orange presumptive condition under 38 CFR 3.309(e). Veterans who were exposed to tactical herbicides including Agent Orange during qualifying service — in Vietnam, the Korean Demilitarized Zone between April 1, 1968 and August 31, 1971, at stateside testing locations, or at other covered locations — do not need to prove a direct medical connection between their exposure and their Hodgkin's diagnosis.
The Blue Water Navy Vietnam Veterans Act of 2019 extended the presumptive to veterans who served on ships in the territorial seas off the coast of the Republic of Vietnam. Veterans previously denied on the basis of offshore service may now file or reopen their claims.
Importantly, Hodgkin's disease treated with radiation to the chest frequently produces secondary hypothyroidism, cardiovascular disease, and secondary malignancies years or decades after the original cancer was cured. Veterans who were treated for Hodgkin's disease and have since developed these secondary conditions may be entitled to additional ratings for the downstream health effects of treatment.
2. VA Rating Criteria
Hodgkin's disease is rated under 38 CFR § 4.117, Diagnostic Code 7709 (Hodgkin's Disease).
Active disease or treatment: A 100% rating applies during any period of active Hodgkin's disease or during any treatment — including combination chemotherapy (ABVD or similar regimens), radiation therapy, or combined modality treatment.
Post-treatment: Following completion of treatment, the 100% rating continues for a minimum of six months. After that period, the VA schedules a rating examination to assess residual disability.
Residual ratings: Common residuals after Hodgkin's disease treatment include:
- Peripheral neuropathy from chemotherapy (particularly vincristine and bleomycin)
- Pulmonary toxicity from bleomycin (bleomycin-induced pneumonitis and fibrosis)
- Cardiovascular disease from chest radiation (coronary artery disease, valvular disease, cardiomyopathy)
- Hypothyroidism from radiation to the neck and mediastinum
- Secondary malignancies, particularly breast cancer, lung cancer, and other lymphomas from prior radiation exposure
Each residual is rated separately under the applicable diagnostic code. The long-term treatment-related effects of Hodgkin's disease — particularly the radiation-induced secondary conditions — represent a significant and frequently unclaimed category of disability for veterans who were treated years or decades ago.
Bleomycin-induced pulmonary toxicity, which produces pulmonary fibrosis and restrictive lung disease, is rated under the respiratory schedule based on pulmonary function test results (FEV1, FVC, DLCO).
Radiation-induced cardiovascular disease is rated under the cardiac diagnostic codes based on functional capacity and ejection fraction.
3. What to Expect at Your C&P Exam
For active disease or current treatment, the examiner confirms the diagnosis, treatment status, and functional limitations. The 100% rating is applied during active disease without further functional assessment.
For a residual exam after treatment, the examiner will assess current hematologic status and evaluate each residual condition. Be prepared to describe:
- Neuropathy symptoms in the hands and feet — numbness, tingling, weakness
- Breathing limitations from pulmonary toxicity — shortness of breath with exertion, reduced exercise tolerance
- Cardiac symptoms — chest pain, palpitations, shortness of breath with activity
- Thyroid symptoms — fatigue, cold intolerance, weight gain, cognitive slowing
- Any symptoms of secondary malignancy
For each secondary condition, bring the relevant specialist records: pulmonology, cardiology, endocrinology, or oncology. These residuals are separately ratable and require separate documentation.
If your Hodgkin's was treated years or decades ago and you have not filed for the treatment-related secondary conditions, a residual rating exam is the opportunity to document them. Request evaluation of all residuals at the time of the exam.
4. Evidence You Need to Win
Diagnosis: Pathology report confirming Hodgkin's lymphoma with Reed-Sternberg cells, staging information, and all oncology treatment records including chemotherapy summaries and radiation field documentation.
Service Record Evidence (Presumptive Claims): Documentation of qualifying service in Vietnam, the Korean DMZ, or other covered herbicide-exposure locations. For Blue Water Navy veterans, ship logs confirming vessel assignment.
No Nexus Letter Required for Presumptive Claims: If the Agent Orange presumptive applies, document the diagnosis and qualifying service and file.
Nexus Letter (Non-Presumptive Direct Claims): Veterans with Hodgkin's disease arising from another service-connected pathway (radiation exposure, occupational chemical exposure) need a hematologist's or oncologist's nexus opinion.
Residual Condition Evidence: Specialist records for each treatment-related secondary condition:
- Pulmonology records and PFT results for bleomycin pulmonary toxicity
- Cardiology records, echocardiogram, and stress test results for radiation-induced cardiac disease
- Endocrinology records and thyroid function tests for hypothyroidism
- All relevant imaging and pathology for any secondary malignancies
DBQ Form: The hematologic malignancy or lymphoma DBQ. Your treating oncologist or hematologist should complete this form with current diagnosis, treatment status, and residual assessment. Separate DBQs may be needed for each major residual condition.
Personal Statement: Describe the functional impact of active disease, treatment, and all current residuals. Note the years of treatment and the long-term effects that have developed since the original cancer.
Buddy Statements (VA Form 21-10210): Family members or caregivers who can describe the functional burden of the disease, treatment, and residual conditions provide lay corroboration.
5. Secondary Conditions to Consider
Hypothyroidism: Radiation to the neck and mediastinum damages the thyroid gland and causes hypothyroidism in a significant percentage of Hodgkin's survivors. This is one of the most commonly missed secondary claims in this population. Obtain thyroid function tests and file for hypothyroidism as a condition secondary to service-connected Hodgkin's disease and its radiation treatment.
Cardiovascular Disease: Mediastinal radiation causes premature coronary artery disease, valvular heart disease, and cardiomyopathy. Veterans treated for Hodgkin's disease in their 20s or 30s may present with significant cardiac disease in their 40s or 50s that is directly attributable to prior radiation. File for secondary cardiovascular conditions with a cardiologist's nexus letter.
Pulmonary Fibrosis: Bleomycin-induced pulmonary toxicity and radiation-induced lung injury produce restrictive pulmonary disease. Secondary pulmonary fibrosis is ratable under the respiratory schedule based on measured pulmonary function impairment.
Secondary Malignancies: Prior treatment with alkylating agents and radiation significantly elevates the risk of therapy-related myeloid neoplasms, breast cancer, lung cancer, and other secondary cancers. If a secondary cancer develops, it may be ratable as a condition secondary to service-connected Hodgkin's disease and its treatment.
Peripheral Neuropathy: Vincristine and other chemotherapy agents used for Hodgkin's disease cause peripheral neuropathy. Secondary neuropathy from treatment of service-connected Hodgkin's is ratable.
Depression and Anxiety: The psychological burden of cancer and long-term monitoring for recurrence and secondary conditions produces secondary psychiatric conditions in many survivors.
6. Common Mistakes That Kill Claims
Not filing because the cancer is "cured." Service connection does not require active disease. A veteran cured of Hodgkin's disease retains service connection, and residuals of the disease and its treatment remain ratable for life. File for the original condition and all treatment-related residuals regardless of cure status.
Missing the hypothyroidism secondary claim. This is the most commonly overlooked secondary claim in Hodgkin's survivors. Radiation to the neck and mediastinum causes hypothyroidism in a large proportion of treated patients, often appearing years after treatment. Get thyroid function tested and file.
Missing the radiation cardiac secondary claim. Veterans treated with mediastinal radiation in the 1970s, 1980s, or 1990s are now reaching the age when radiation-induced cardiovascular disease manifests. Many have never connected their heart disease to their prior Hodgkin's treatment or their VA benefits. A cardiologist's nexus letter connecting radiation-induced cardiac disease to service-connected Hodgkin's treatment is the path to service connection.
Not pursuing Blue Water Navy coverage. Offshore Vietnam veterans denied before 2019 may reopen their claims under the Blue Water Navy Vietnam Veterans Act.
Failing to document residuals before the post-treatment rating exam. Veterans who do not bring specialist records documenting pulmonary function, cardiac status, and thyroid function to the residual rating exam may receive a 0% residual rating by default. Gather and present all residual evidence at the time of the exam.
7. FWD Assist Resources
The following FWD Assist HQ books are directly relevant to a Hodgkin's disease claim:
- Agent Orange: The Complete Vietnam Veterans Claims Guide — comprehensive coverage of the presumptive list including Hodgkin's disease, qualifying service locations, Blue Water Navy provisions, and filing guidance
- Secondary Conditions Guide — covers the Hodgkin's-to-hypothyroidism, Hodgkin's-to-cardiac disease, and Hodgkin's-to-secondary malignancy chains in detail
- C&P Exam Prep Guide — covers what to expect at cancer residual exams and how to document treatment-related residuals for the rating formula
- Nexus Letters Guide — how to brief a cardiologist or endocrinologist to produce a nexus letter connecting radiation-induced secondary conditions to service-connected Hodgkin's treatment
All titles are available at fwdassisthq.com.
8. Get Help Without a Claim Shark
Free, accredited help is available through Veterans Service Organizations including the DAV, VFW, American Legion, and AMVETS. County Veterans Service Officers (CVSOs) file and manage claims at no cost.
Charging upfront fees to assist with a VA claim is illegal under 38 U.S.C. § 5905. VA-accredited attorneys and claims agents may charge fees only after an initial VA decision, capped at 20% of past-due benefits under 38 U.S.C. § 5904. No legitimate representative asks for money before your first decision.
Verify accreditation at va.gov/ogc/accreditation.asp.